SAADH, M. J. “SARS-COV-2 3CL-PROTEASE INHIBITORS AS ANTIVIRAL AGENT AGAINST COVID-19”. International Journal of Applied Pharmaceutics, vol. 14, no. 6, Nov. 2022, pp. 18-20, doi:10.22159/ijap.2022v14i6.46015.